ACURA PHARMACEUTICALS INC Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ACUR and buy or sell other stocks, ETFs, and their options commission-free!

About ACUR

Acura Pharmaceuticals, Inc. is a drug delivery company, which engages in the research, development, and commercialization of technologies and products intended to address safe use of medications. Its technology platforms include Aversion, Impede, and LIMITx. 

CEO
Robert B. Jones
CEORobert B. Jones
Employees
9
Employees9
Headquarters
Palatine, Illinois
HeadquartersPalatine, Illinois
Founded
1935
Founded1935
Employees
9
Employees9

ACUR Key Statistics

Market cap
6.60K
Market cap6.60K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.07K
Average volume1.07K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.01
52 Week high$0.01
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

The current ACURA PHARMACEUTICALS INC Common Stock(ACUR) stock price is $0.00, with a market capitalization of 6.6K.

ACURA PHARMACEUTICALS INC Common Stock(ACUR) stock opened on 2026-07-16 at —. The price climbed to — and dipped to —.

The ACURA PHARMACEUTICALS INC Common Stock(ACUR)'s current trading volume is 0, compared to an average daily volume of 1.07K.

In the last year, ACURA PHARMACEUTICALS INC Common Stock(ACUR) shares hit a 52-week high of $0.01 and a 52-week low of $0.00.

In the last year, ACURA PHARMACEUTICALS INC Common Stock(ACUR) shares hit a 52-week high of $0.01 and a 52-week low of $0.00.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.